Suppr超能文献

一种使磺脲类受体失活的点突变导致了芬兰婴儿期严重形式的持续性高胰岛素血症性低血糖症。

A point mutation inactivating the sulfonylurea receptor causes the severe form of persistent hyperinsulinemic hypoglycemia of infancy in Finland.

作者信息

Otonkoski T, Ammälä C, Huopio H, Cote G J, Chapman J, Cosgrove K, Ashfield R, Huang E, Komulainen J, Ashcroft F M, Dunne M J, Kere J, Thomas P M

机构信息

Transplantation Laboratory, Haartman Institute,and University of Helsinki, Finland.

出版信息

Diabetes. 1999 Feb;48(2):408-15. doi: 10.2337/diabetes.48.2.408.

Abstract

Mutations in genes encoding the ATP-regulated potassium (K(ATP)) channels of the pancreatic beta-cell (SUR1 and Kir6.2) are the major known cause of persistent hyperinsulinemic hypoglycemia of infancy (PHHI). We collected all cases of PHHI diagnosed in Finland between 1983 and 1997 (n = 24). The overall incidence was 1:40,400, but in one area of Central Finland it was as high as 1:3,200. Haplotype analysis using polymorphic markers spanning the SUR1/Kir6.2 gene cluster confirmed linkage to the 11p region. Sequence analysis revealed a novel point mutation in exon 4 of SUR1, predicting a valine to aspartic acid change at amino acid 187 (V187D). Of the total cases, 15 affected individuals harbored this mutation in heterozygous or homozygous form, and all of these had severe hyperinsulinemia that responded poorly to medical treatment and required subtotal pancreatectomy. No K(ATP) channel activity was observed in beta-cells isolated from a homozygous patient or after coexpression of recombinant Kir6.2 and SUR1 carrying the V187D mutation. Thus, the mutation produces a nonfunctional channel and, thereby, continuous insulin secretion. This unique SUR1 mutation explains the majority of PHHI cases in Finland and is strongly associated with a severe form of the disease. These findings provide diagnostic and prognostic utility for suspected PHHI patients.

摘要

编码胰腺β细胞ATP调节钾通道(K(ATP),由SUR1和Kir6.2组成)的基因突变是已知导致婴儿持续性高胰岛素血症性低血糖症(PHHI)的主要原因。我们收集了1983年至1997年间在芬兰诊断的所有PHHI病例(n = 24)。总体发病率为1:40,400,但在芬兰中部的一个地区高达1:3,200。使用跨越SUR1/Kir6.2基因簇的多态性标记进行单倍型分析,证实与11p区域连锁。序列分析显示SUR1外显子4中有一个新的点突变,预测第187位氨基酸由缬氨酸变为天冬氨酸(V187D)。在所有病例中,15名受影响个体以杂合或纯合形式携带此突变,所有这些个体都有严重的高胰岛素血症,对药物治疗反应不佳,需要进行胰腺次全切除术。从一名纯合患者分离的β细胞中,或在共表达携带V187D突变的重组Kir6.2和SUR1后,均未观察到K(ATP)通道活性。因此,该突变产生了无功能的通道,从而导致胰岛素持续分泌。这种独特的SUR1突变解释了芬兰大多数PHHI病例,并且与该疾病的严重形式密切相关。这些发现为疑似PHHI患者提供了诊断和预后依据。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验